Toggle navigation
Share
About Us
Vision & Values
Leadership
History
Collaborations
In the Community
Careers
Media Gallery
Contact CTI
Products
PIXUVRI
®
Development
Pipeline
Pacritinib
Pixantrone
Tosedostat
Paclitaxel Poliglumex
Publications
Clinical Trials
Clinical Trial Overview
Physician Resources
Patient Resources
Investors
Overview
News
Stock
Stock Chart
Historical Price Lookup
Investment Calculator
Transfer Agent
SEC Filings
Analyst Coverage
Events & Webcasts
Annual Report
Shareholder Meeting
Financial Details
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Corporate Governance
Committee Composition
Leadership Bios
Board of Directors
Governance Documents
Whistleblower Hotline
Investor FAQ
Information Request
Email Alerts
Investors
Overview
News
Stock
Stock Chart
Historical Price Lookup
Investment Calculator
Transfer Agent
SEC Filings
Analyst Coverage
Events & Webcasts
Annual Report
Shareholders Meeting
Financial Details
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Corporate Governance
Leadership Bios
Board of Directors
Whistleblower Hotline
Investor FAQ
Information Request
Email Alerts
Info Tools
Print Page
Email Page
RSS Feed
Email Alerts
IR Contacts
Tear Sheet
Most Viewed Links
SEC Filings
CTI BioPharma Receives Results of the CHMP Oral Explanation for Pacritinib in the Treatment of Myelofibrosis and Provides Development Update
Events & Webcasts
Annual Report
Stock Quote
Definition
<<
Back
Cash from Financing Activities
Cash From Financing Activities represents the sum of:
Financing Cash Flow Items
Cash Dividends Paid
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net.